<p>Ruth Connor of Symbiora Inc. in the U.S. will evaluate the safety and effectiveness of a low-cost oral solution derived from beneficial strains of human gut bacteria to prevent and treat acute diarrheal illness in infants.</p>


Ruth Connor of Symbiora Inc. in the U.S. will evaluate the safety and effectiveness of a low-cost oral solution derived from beneficial strains of human gut bacteria to prevent and treat acute diarrheal illness in infants.

Microbial-Based Oral Solution to Prevent Diarrhea in Infants

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.